Literature DB >> 30598365

Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy.

Dustin Hang1, Hartzell V Schaff2, Rick A Nishimura3, Brian D Lahr4, Martin D Abel5, Joseph A Dearani1, Steve R Ommen3.   

Abstract

BACKGROUND: Mitral valve regurgitation (MR) mediated by systolic anterior motion (SAM) in obstructive hypertrophic cardiomyopathy (HCM) is traditionally characterized by a posteriorly directed jet on Doppler echocardiography. Many believe that MR in the absence of a posteriorly directed jet signals the presence of intrinsic mitral valve (MV) disease.
METHODS: A total of 709 adult patients with obstructive HCM who underwent septal myectomy were evaluated; 330 of these patients had >2 + MR preoperatively and constituted the study group. SAM-mediated MR was defined as MR that was eliminated or substantially reduced by myectomy for relief of left ventricular outflow tract obstruction with no need for MV intervention.
RESULTS: On preoperative transthoracic echocardiography, 168 of 258 patients with SAM-mediated MR and nine of 28 patients with intrinsic MV disease had isolated posterior jets, corresponding to sensitivity and specificity of 65.1% and 67.9% for identifying SAM-mediated MR; the positive predictive value was 94.9% and the negative predictive value was 17.4%. On prebypass transesophageal echocardiography, 169 of 284 patients with SAM-mediated MR and five of 28 patients with intrinsic MV disease had isolated posterior jets, corresponding to sensitivity and specificity of 59.5% and 82.1%; the positive predictive value and negative predictive value were 97.1% and 16.7%.
CONCLUSION: A posteriorly directed jet of MR in obstructive HCM correlates highly with SAM as the underlying pathophysiologic mechanism, but because of the low negative predictive value, clinicians should be cautious in using the jet direction of MR on preoperative transthoracic echocardiography to guide the decision for concomitant MV surgery during septal myectomy for HCM.
Copyright © 2018 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostic accuracy; Doppler echocardiography; Mitral regurgitation; Mitral valve; Obstructive hypertrophic cardiomyopathy; Systolic anterior motion

Year:  2018        PMID: 30598365     DOI: 10.1016/j.echo.2018.10.011

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  6 in total

Review 1.  Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Joon Hwa Hong; Anita Nguyen; Hartzell Vernon Schaff
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-05-07

2.  Pathoanatomy of Mitral Regurgitation.

Authors:  Ilya Karagodin; Amita Singh; Roberto M Lang
Journal:  Struct Heart       Date:  2020-06-12

3.  4D flow MRI left atrial kinetic energy in hypertrophic cardiomyopathy is associated with mitral regurgitation and left ventricular outflow tract obstruction.

Authors:  Aakash N Gupta; Gilles Soulat; Ryan Avery; Bradley D Allen; Jeremy D Collins; Lubna Choudhury; Robert O Bonow; James Carr; Michael Markl; Mohammed S M Elbaz
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-01       Impact factor: 2.357

4.  Does the Flow Know? Mitral Regurgitant Jet Direction and Need for Valve Repair in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Ehud Schwammenthal; Albert A Hagège; Robert A Levine
Journal:  J Am Soc Echocardiogr       Date:  2019-03       Impact factor: 5.251

Review 5.  Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.

Authors:  Sarah A Guigui; Christian Torres; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

6.  Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR.

Authors:  Aakash N Gupta; Ryan Avery; Gilles Soulat; Bradley D Allen; Jeremy D Collins; Lubna Choudhury; Robert O Bonow; James Carr; Michael Markl; Mohammed S M Elbaz
Journal:  J Cardiovasc Magn Reson       Date:  2021-12-06       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.